These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6127039)

  • 1. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new beta 2-adrenoceptor agonist--D 2343--with long duration. Inhalation comparison with terbutaline in asthmatics.
    Löfdahl CG; Svedmyr N
    Allergy; 1984 Aug; 39(6):485-9. PubMed ID: 6437263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
    Scalabrin DM; Solé D; Naspitz CK
    J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does theophylline potentiate inhaled beta 2-agonists?
    Svedmyr K; Svedmyr N
    Allergy; 1982 Feb; 37(2):101-10. PubMed ID: 6127963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prenalterol in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
    Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of different nebulized bronchodilators on clinical efficacy and hypokalemia in asthmatic children.
    Hung CH; Hua YM; Lee MY; Tsai YG; Yang KD
    Acta Paediatr Taiwan; 2001; 42(5):287-90. PubMed ID: 11729705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of beta-adrenergic stimulating and blocking agents.
    Löfdahl CG; Svedmyr N
    Eur J Respir Dis Suppl; 1984; 136():101-13. PubMed ID: 6145618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of beta 2-adrenoceptor stimulation in bronchial and skeletal muscle in experimental and clinical studies.
    Löfdahl CG; Svedmyr K; Svedmyr N; Andersson P; Bengtsson B; Olsson OA; Waldeck B
    Eur J Respir Dis Suppl; 1984; 135():124-7. PubMed ID: 6329798
    [No Abstract]   [Full Text] [Related]  

  • 13. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
    Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
    Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Ullman A; Svedmyr N
    Thorax; 1988 Sep; 43(9):674-8. PubMed ID: 2904183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics.
    Svedmyr K
    Allergy; 1982 Feb; 37(2):119-27. PubMed ID: 6127964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of bronchodilation and finger tremor induced by salmeterol and salbutamol in asthmatic patients.
    Lötvall J; Lunde H; Svedmyr N
    Can Respir J; 1998; 5(3):191-4. PubMed ID: 9707465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
    Löfdahl CG; Svedmyr N
    Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of xamoterol (ICI 118,587) in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Br J Clin Pharmacol; 1984 Oct; 18(4):597-601. PubMed ID: 6148960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.